
Stock Price Target Changes
JPMorgan Chase lowered the stock price target for CONMED (NASDAQ:CNMD) from $136 to $76. The brokerage gave the stock an Overweight rating. CNMD stock closed at $65.64 on April 23. BMO Capital Markets lowered the ... [Read]